Delivery Order SPE2DB22D2007-SPE2DB25FJ4EK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Adapalene 0.1% Cream in 45-gram units, with a ceiling value of $4,509.24. This is a firm fixed price, non-set-aside competitively awarded contract with an ultimate completion date of August 28, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Adapalene 0.1% Cream in 45-gram units, with a ceiling value of $1,241.06 and a firm fixed price structure. This non-set-aside contract is set for completion by August 15, 2025, and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $5,044.01 to AmerisourceBergen Drug Corp for Adapalene 0.1% cream on August 27, 2025, with an ultimate completion date of September 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,252.49 to AmerisourceBergen Drug Corp for the supply of Adapalene 0.1% Cream in 45-gram quantities. This firm fixed-price contract, awarded on August 13, 2025, represents a non-set-aside, competitively awarded procurement action with an ultimate completion date of August 14, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, serving as the place of performance. This delivery order is...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,870.15 firm fixed-price order is for the supply of Adapalene 0.1% cream, a topical acne medication. The contract has an ultimate completion date of September 20, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a...
- This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of Adapalene 0.1% cream. The award, valued at $1,398.36, has a firm-fixed price pricing type and an ultimate completion date of August 15, 2024. This contract does not have a set-aside designation. Amerisourcebergen, through its Corporate Office division, will provide the specified pharmaceutical product to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,016.73, is for the delivery of Adapalene 0.1% Cream 45GM, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 19, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award, valued at $4,831.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Adapalene 0.1% Cream, a topical medication, with a period of performance through June 20, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,001.70, is a Delivery Order contract with a Firm Fixed Price pricing type and an ultimate completion date of January 31, 2025. The contract is for the supply of Adapalene 0.1% Cream, a pharmaceutical product, to support military healthcare programs. Amerisourcebergen holds a significant...
- This federal contract award, valued at $2,831.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Adapalene 0.1% Cream, a topical medication, with a completion date of March 12, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4EKDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on August 20, 2025, for Adapalene 0.1% Cream in 45-gram quantities. The contract is valued at $1,423.93 under a firm fixed price structure with an ultimate completion date of August 21, 2025. This award represents a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that supports pharmaceutical and medical supply needs for military healthcare systems globally. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, supplying a comprehensive range of medications and medical commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates consistent capability to fulfill open competition requirements across multiple therapeutic domains, with delivery orders ranging from small-value transactions to substantial orders. This particular delivery order for the topical dermatological medication reflects the company's ongoing role as a major provider within the DLA's pharmaceutical supply chain supporting military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/20/25 |